USP17L20: A Drug Target / Disease Biomarker (G100287441)

USP17L20: A Drug Target / Disease Biomarker

USP17L20 is a protein that is expressed in various tissues throughout the body, including the brain, heart, liver, and kidneys. It is a member of the USP family of transmembrane proteins, which are characterized by the presence of a transmembrane region that spans the cell membrane and functions as an extracellular protein that can interact with other proteins or cell surface molecules.

USP17L20 is involved in a number of cellular processes that are important for normal physiological function. One of its well-known functions is in the regulation of cell death, which is a critical process that helps maintain tissue homeostasis and ensure the survival of cells. USP17L20 is involved in the formation of the stress-protein-activated signaling pathway, which is a critical pathway that helps cells respond to stress and ensure their survival in the face of external stimuli.

Another function of USP17L20 is in the regulation of cell signaling, specifically in the signaling pathway that is responsible for the regulation of cell growth and differentiation. This pathway is critical for the development, maintenance, and regulation of tissues and organs, and is a key factor in the development of cancer. USP17L20 is thought to be involved in the regulation of this pathway by interacting with the protein p21, which is a key negative regulator of the RAS/MAPK signaling pathway.

In addition to its role in cell signaling and stress response, USP17L20 is also involved in the regulation of cell adhesion and migration. This is an important function for cells, as it allows them to move and divide in a specific direction, and to stick to specific cell-cell and cell-extracellular matrix interactions. USP17L20 is thought to be involved in this process through its interaction with the protein vimentin, which is a component of the cytoskeleton.

Finally, USP17L20 is also involved in the regulation of inflammation, which is an important function for immune cells and for maintaining tissue homeostasis. This is an important function for cells, as it helps to prevent the excessive growth and spread of immune cells, which can cause tissue damage and inflammation. USP17L20 is thought to be involved in this process through its interaction with the protein NF-kappa-B, which is a key regulator of inflammation.

In conclusion, USP17L20 is a protein that is involved in a number of important cellular processes that are essential for normal tissue function and development. Its functions in the regulation of cell death, signaling, adhesion, and migration, as well as its role in the regulation of inflammation, make USP17L20 an important target for drug development. Further research is needed to fully understand the role of USP17L20 in these processes and to develop effective treatments for this protein.

Protein Name: Ubiquitin Specific Peptidase 17 Like Family Member 20

Functions: Deubiquitinating enzyme that removes conjugated ubiquitin from specific proteins to regulate different cellular processes that may include cell proliferation, progression through the cell cycle, apoptosis, cell migration, and the cellular response to viral infection

The "USP17L20 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about USP17L20 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

USP17L21 | USP17L24 | USP17L25 | USP17L26 | USP17L27 | USP17L29 | USP17L3 | USP17L5 | USP17L6P | USP17L7 | USP17L8 | USP17L9P | USP18 | USP19 | USP2 | USP2-AS1 | USP20 | USP21 | USP22 | USP24 | USP25 | USP26 | USP27X | USP27X-DT | USP28 | USP29 | USP3 | USP3-AS1 | USP30 | USP30-AS1 | USP31 | USP32 | USP32P1 | USP32P2 | USP32P3 | USP33 | USP34 | USP35 | USP36 | USP37 | USP38 | USP39 | USP4 | USP40 | USP41 | USP42 | USP43 | USP44 | USP45 | USP46 | USP46-DT | USP47 | USP48 | USP49 | USP5 | USP50 | USP51 | USP53 | USP54 | USP6 | USP6NL | USP6NL intronic transcript 1 (non-protein coding), transcript variant 1 | USP7 | USP8 | USP8P1 | USP9X | USP9Y | USPL1 | UST | UTF1 | UTP11 | UTP14A | UTP14C | UTP15 | UTP18 | UTP20 | UTP23 | UTP25 | UTP3 | UTP4 | UTP6 | UTRN | UTS2 | UTS2B | UTS2R | UTY | UVRAG | UVSSA | UXS1 | UXT | UXT-AS1 | VAC14 | Vacuolar H+ ATPase | VAMP1 | VAMP2 | VAMP3 | VAMP4 | VAMP5 | VAMP7 | VAMP8